Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gartner Inc (IT) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Gartner IncTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Gartner Inc vs uniQure N.V. Ordinary Shares — how do they compare? Gartner Inc trades at $197.21 (market cap $12.44B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Gartner Inc is far larger — about 8.4× uniQure N.V. Ordinary Shares's market cap, and Gartner Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gartner Inc for 65 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

ITQURE
Market Cap
$12.44B$1.48B
Volume
818,5872,488,780
Sector
TechnologyHealth
52-Week High
$258.17$70.59
52-Week Low
$125.68$9.03
Typical Hold Time
65 Days0 Days
Enterprise Value
$14.18B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gartner Inc

Gartner Inc. (IT) trades at $195.77, up 0.86% on the day, with a bullish technical signal and strong profitability metrics including a 69.63% gross margin and 113.58% ROE. Recent earnings beats and positive news flow around AI advisory demand support the stock, though net cash flow turned negative in 2025. The current price sits above the consensus target of $178.14, indicating potential overvaluation concerns among analysts.

Outlook remains positive due to robust contract value growth and AI-driven demand, but risks include volatile cash flows, high P/B ratio of 160.06, and a shareholder investigation. Investor sentiment is mixed with 55.55% hold ratings, suggesting cautious optimism amid execution risks and macroeconomic uncertainty.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IT

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Gartner Inc

Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.

Read more on IT →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →